![]() |
市場調查報告書
商品編碼
1880649
多股/編織可吸收縫合線市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032)Multifilament/Braided Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
全球多股/編織可吸收縫合線市場持續穩定成長,主要受外科領域對先進傷口閉合解決方案需求不斷增長的推動。根據近期一份報告,受慢性病發病率上升和全球外科手術數量增加的推動,該市場規模預計在2024年達到30.4億美元。預計2025年,市場規模將擴大至32億美元,2032年將達到55.1億美元,預測期內複合年增長率(CAGR)為8.0%。
多股或編織可吸收縫合線由加撚或編織的纖維製成,設計用於在體內逐漸溶解。其優異的抗拉強度、柔韌性和牢固的打結性能使其成為內部外科手術的理想選擇,尤其適用於難以拆線的手術。隨著全球外科手術數量的增加,對這類縫線的需求持續成長。
市場推動因素
全球外科手術數量的顯著成長正在推動市場成長。骨科、婦科、整形外科和心血管外科等領域越來越依賴可吸收縫線來促進傷口更快癒合並減輕患者不適。例如,根據國際美容整形外科學會 (ISAPS) 的數據,2022 年全球鼻整形手術數量約為 90 萬例,預計 2023 年將增至 110 萬例。同樣,英國剖腹產率預計將從 2022 年的 34.7% 增加到 2023 年的 37.8%,這將推動外科縫線需求的成長。
老年人口不斷增長,他們易患慢性疾病,需要頻繁接受手術治療,這進一步推動了市場成長。 DemeTECH Corporation、強生服務公司、美敦力公司和貝朗公司等主要公司推出的新產品也增強了全球市場的產品供應。
市場限制因子
儘管需求不斷增長,但由於其他傷口閉合方法的日益普及,市場仍面臨挑戰。由於手術縫合器、組織黏合劑、止血鉗和膠帶具有諸多優勢,例如縫合速度更快、疤痕更少、組織損傷最小,因此在某些手術中越來越受歡迎。例如,根據 Suture Planet 發布的 2025 年報告,與縫線相比,手術縫合器能夠實現更快、更牢固的縫合,尤其是在骨科和開放性手術中。
這種向替代方法的轉變限制了多股/編織縫線的應用,尤其是在醫療體系發達的地區。此外,縫線感染、結節裂開、疤痕形成和組織反應等術後併發症仍然是外科醫生關注的重點。
市場機會
發展中國家醫療基礎設施的不斷改善帶來了巨大的市場機會。隨著亞太地區、拉丁美洲和非洲新醫院和手術中心的不斷湧現,手術總量持續成長。例如,位於新南威爾斯州的格里菲斯基地醫院將於 2025 年 6 月開業,這標誌著支持外科手術護理的基礎設施得到了擴展。
抗菌塗層縫線、合成生物工程材料和無結可吸收縫合線等技術進步也為成長開闢了新的途徑。這些創新正在改善組織癒合、降低感染風險並簡化手術流程。
市場挑戰
監管的複雜性仍然是製造商面臨的主要挑戰。美國 FDA、EMA 和其他監管機構實施的審批流程需要大量的臨床數據,這增加了研發成本並延遲了市場准入,尤其對於中小企業而言更是如此。監管要求的區域差異也使全球市場擴張變得更加複雜。
北美在 2024 年引領全球市場,佔全球市場的 42.76%,市場規模達 13 億美元。強大的醫療基礎設施、高手術量和充足的產品供應支撐了該地區的領先地位。
歐洲將維持適中的市場佔有率,這得益於手術量的成長趨勢,例如德國在2023年進行了100,606例心臟手術。
由於醫療設施的擴張、新產品的推出以及醫療旅遊業的蓬勃發展,亞太地區預計將以最高的複合年增長率增長。 Healthium Medtech公司於2023年推出的TRUMAS縫合線便是該地區創新發展的典型例證。
拉丁美洲和中東/非洲地區預計將保持穩定成長,這主要得益於一般外科、骨科、眼科和心臟護理手術量的成長。
The global multifilament/braided absorbable sutures market continues to grow steadily as demand for advanced wound-closure solutions rises across surgical disciplines. According to the latest report, the market was valued at USD 3.04 billion in 2024, driven by an increasing burden of chronic diseases and a higher volume of surgical procedures worldwide. The market is expected to expand to USD 3.20 billion in 2025 and further reach USD 5.51 billion by 2032, registering a strong CAGR of 8.0% during the forecast period.
Multifilament or braided absorbable sutures are made from twisted or braided strands designed to dissolve inside the body over time. Their superior tensile strength, flexibility, and secure knotting capacity make them ideal for internal surgical procedures, particularly where suture removal is not feasible. As global surgical volumes rise, demand for these sutures continues to accelerate.
Market Drivers
A significant rise in surgical procedures worldwide is driving market growth. Surgeries such as orthopedic, gynecological, cosmetic, and cardiovascular interventions rely heavily on absorbable sutures to promote rapid healing and reduce patient discomfort. For example, around 0.9 million rhinoplasty procedures were performed worldwide in 2022, increasing to 1.1 million in 2023, according to the International Society of Aesthetic Plastic Surgery. Similarly, caesarean deliveries in the U.K. increased from 34.7% in 2022 to 37.8% in 2023, contributing to rising demand for surgical sutures.
An expanding geriatric population, more prone to chronic illness and requiring frequent surgical care, further supports market growth. New product launches by leading players such as DemeTECH Corporation, Johnson & Johnson Services, Inc., Medtronic, and B. Braun SE also strengthen product availability across global markets.
Market Restraints
Despite growing demand, the market faces challenges due to rising adoption of alternative wound-closure methods. Surgical staplers, tissue adhesives, hemostats, and adhesive tapes are increasingly preferred in certain procedures due to benefits such as faster closure, reduced scarring, and minimized tissue trauma. For instance, according to Suture Planet's 2025 report, surgical staplers enable quicker and more secure closure compared to sutures, particularly in orthopedic and laparotomy surgeries.
This shift toward alternatives limits the adoption of multifilament/braided sutures, especially in regions with advanced healthcare systems. Additionally, postoperative complications such as suture infections, knot failures, scarring, and tissue reactions remain significant concerns among surgeons.
Market Opportunities
Expanding healthcare infrastructure in developing countries offers significant market opportunities. As new hospitals and surgical centers open across Asia Pacific, Latin America, and Africa, the overall number of surgical procedures continues to rise. For instance, Griffith Base Hospital opened in New South Wales in June 2025, illustrating the expanding infrastructure supporting surgical care.
Technological advancements-such as antimicrobial-coated sutures, synthetic bioengineered materials, and knotless absorbable sutures-are also creating new growth avenues. These innovations improve tissue healing, reduce infection risk, and simplify surgical workflows.
Market Challenges
Regulatory complexities remain a major challenge for manufacturers. Approval processes enforced by the U.S. FDA, EMA, and other regulatory bodies require extensive clinical data, increasing development costs and delaying market entry-particularly for small and mid-sized companies. Differences in regulatory requirements across regions further complicate global market expansion.
North America dominated the global market in 2024 with a market size of USD 1.30 billion, accounting for 42.76% of global share. Strong healthcare infrastructure, high surgical volumes, and extensive product availability fuel regional dominance.
Europe holds a moderate share, supported by rising surgical procedures such as the 100,606 cardiac surgeries performed in Germany in 2023.
Asia Pacific is expected to grow at the fastest CAGR due to expanding healthcare facilities, new product launches, and increasing medical tourism. Healthium Medtech's launch of TRUMAS sutures in 2023 highlights the region's growing innovation landscape.
Latin America and the Middle East & Africa will experience steady growth, supported by rising surgical volumes in general, orthopedic, ophthalmic, and cardiac care.
Conclusion
Projected to grow from USD 3.04 billion in 2024 to USD 5.51 billion by 2032, the multifilament/braided absorbable sutures market is set for robust expansion. Increasing surgical procedures, technological innovation, and expanding healthcare infrastructure will remain key drivers, despite challenges from alternative wound-closure methods and regulatory complexities.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa